Early research (Phase 1)Active Not RecruitingNCT02650414What this trial is testingCD22 Redirected Autologous T Cells for ALLWho this might be right forB Cell LeukemiasB Cell Lymphomas University of Pennsylvania 41
Not applicableEnded earlyNCT00957736What this trial is testingChronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell TransplantWho this might be right forCancer Vanderbilt-Ingram Cancer Center 252
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07175415What this trial is testingHEM-iSMART E: Capivasertib + Venetoclax + Dexamethasone in Pediatric Patients With Relapsed or Refractory Hematological MalignanciesWho this might be right forAcute Lymphoblastic LeukemiaLymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) RecurrentLymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Refractory+2 more Princess Maxima Center for Pediatric Oncology
Early research (Phase 1)Study completedNCT02141828What this trial is testingDose Escalation and Expanded Cohort Study of EPZ-5676 in the Treatment of Pediatric Patients With Relapsed/Refractory Leukemias Bearing a Rearrangement of the MLL GeneWho this might be right forLeukemiaAcute Myeloid LeukemiaAcute Lymphocytic Leukemia+1 more Epizyme, Inc. 18
Early research (Phase 1)WithdrawnNCT07498465What this trial is testingFind the Highest Dose of SNDX-5613 (Revumenib) as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, and Mixed Phenotype Acute LeukemiaWho this might be right forAcute Lymphoblastic LeukemiaAcute Myeloid LeukemiaChildhood Acute Lymphoblastic Leukemia+3 more Children's Oncology Group
Not applicableStudy completedNCT06376188What this trial is testingImproving Breaking Bad News in Pediatrics by Simulated CommunicationWho this might be right forCommunicationEnd of LifePediatric ALL Medical University of Vienna 46
Very early researchNot Yet RecruitingNCT07406178What this trial is testingJY509 Universal NK Cell Injection for the Treatment of Relapsed/Refractory Pediatric B-ALLWho this might be right forRelapsed/Refractory Pediatric B-ALL Institute of Hematology & Blood Diseases Hospital, China 18
Testing effectiveness (Phase 2)Study completedNCT00003735What this trial is testingChemotherapy in Treating Children With Relapsed Acute Leukemia, Acute Myeloid Leukemia, or Blastic Phase Chronic Myelogenous LeukemiaWho this might be right forLeukemia Children's Oncology Group 11
Post-approval studies (Phase 4)UnknownNCT00846703What this trial is testingThe GD-2008 ALL Protocol for Childhood Acute Lymphoblastic LeukemiaWho this might be right forAcute Lymphoblastic Leukemia Sun Yat-sen University 600
Testing effectiveness (Phase 2)Ended earlyNCT03743246What this trial is testingEvaluate the Safety and Efficacy of JCAR017 in Pediatric Subjects With Relapsed/Refractory (r/r) B-cell Acute Lymphoblastic Leukemia (B-ALL) and B-cell Non-Hodgkin Lymphoma (B-NHL)Who this might be right forPrecursor Cell Lymphoblastic Leukemia-LymphomaLymphoma, Non-Hodgkin Celgene 21
Testing effectiveness (Phase 2)Study completedNCT00021242What this trial is testingDocetaxel in Treating Children With Relapsed or Refractory Acute Lymphoblastic or Acute Myeloid LeukemiaWho this might be right forLeukemia Children's Oncology Group 12
Large-scale testing (Phase 3)Study completedNCT00002812What this trial is testingCombination Chemotherapy in Treating Children With Acute Lymphocytic LeukemiaWho this might be right forLeukemia Children's Oncology Group 2,078
Testing effectiveness (Phase 2)Active Not RecruitingNCT03301168What this trial is testingStudy of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell TransplantWho this might be right forAcute Lymphoblastic LeukemiaLeukemia, Acute Myeloid (AML), ChildLymphoma, Non-Hodgkin+6 more Bellicum Pharmaceuticals 120
Not applicableStudy completedNCT05565040What this trial is testingConcealed Penis in Pediatric Age GroupWho this might be right forPediatric ALLSurgeryUrologic Diseases Egyptian Biomedical Research Network 150
Large-scale testing (Phase 3)Study completedNCT00186901What this trial is testingA Severity-Adapted Clinical Trial of Diminished Bone Mineral Density in Acute Lymphoblastic Leukemia SurvivorsWho this might be right forLeukemia, Lymphoblastic, AcuteOsteoporosis St. Jude Children's Research Hospital 429
Not applicableStudy completedNCT03471416What this trial is testingNutritional Status in Children With ALL in GuatemalaWho this might be right forAcute Lymphoblastic Leukemia Columbia University 109
Not applicableStudy completedNCT05866887What this trial is testingInsomnia Prevention in Children With Acute Lymphoblastic LeukemiaWho this might be right forPediatric Acute Lymphoblastic LeukemiaLeukemiaAcute Lymphoblastic Leukemia Dana-Farber Cancer Institute 25
Testing effectiveness (Phase 2)Study completedNCT00806767What this trial is testingFludarabine, Busulfan, and Antilymphocyte Globulin Followed by Donor Stem Cell Transplant in Treating Older Patients With Hematological CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+3 more Institut Paoli-Calmettes 82
Not applicableLooking for participantsNCT06938009What this trial is testingDutch Registry of Pediatric Cardiac ArrestWho this might be right forCardiac Arrest (CA)Pediatric ALL Matthijs de Hoog 500
Early research (Phase 1)Study completedNCT00363272What this trial is testingIspinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or LymphomaWho this might be right forChildhood Burkitt LymphomaChildhood Central Nervous System Germ Cell TumorChildhood Choroid Plexus Tumor+22 more National Cancer Institute (NCI) 30